Citigroup’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Sell |
32,549
-71,557
| -69% | -$726K | ﹤0.01% | 3132 |
|
|
2025
Q1 | $581K | Buy |
104,106
+32,312
| +45% | +$180K | ﹤0.01% | 2866 |
|
|
2024
Q4 | $579K | Buy |
71,794
+25,794
| +56% | +$208K | ﹤0.01% | 2932 |
|
|
2024
Q3 | $472K | Buy |
46,000
+18,510
| +67% | +$190K | ﹤0.01% | 3026 |
|
|
2024
Q2 | $194K | Sell |
27,490
-106,416
| -79% | -$752K | ﹤0.01% | 3170 |
|
|
2024
Q1 | $1.84M | Buy |
133,906
+127,343
| +1,940% | +$1.75M | ﹤0.01% | 1892 |
|
|
2023
Q4 | $60.4K | Buy |
6,563
+6,538
| +26,152% | +$60.1K | ﹤0.01% | 3691 |
|
|
2023
Q3 | $151 | Sell |
25
-11,599
| -100% | -$70.1K | ﹤0.01% | 4586 |
|
|
2023
Q2 | $90.2K | Sell |
11,624
-33,464
| -74% | -$260K | ﹤0.01% | 3628 |
|
|
2023
Q1 | $257K | Buy |
+45,088
| New | +$257K | ﹤0.01% | 2971 |
|
|
2022
Q4 | – | Sell |
-474
| Closed | -$2K | – | 5016 |
|
|
2022
Q3 | $2K | Sell |
474
-476
| -50% | -$2.01K | ﹤0.01% | 4707 |
|
|
2022
Q2 | $4K | Sell |
950
-4,992
| -84% | -$21K | ﹤0.01% | 4921 |
|
|
2022
Q1 | $32K | Sell |
5,942
-55,291
| -90% | -$298K | ﹤0.01% | 4216 |
|
|
2021
Q4 | $900K | Buy |
61,233
+34,680
| +131% | +$510K | ﹤0.01% | 2652 |
|
|
2021
Q3 | $556K | Sell |
26,553
-57,876
| -69% | -$1.21M | ﹤0.01% | 2816 |
|
|
2021
Q2 | $1.49M | Sell |
84,429
-4,308
| -5% | -$76.2K | ﹤0.01% | 2325 |
|
|
2021
Q1 | $2.17M | Buy |
88,737
+80,094
| +927% | +$1.96M | ﹤0.01% | 1882 |
|
|
2020
Q4 | $293K | Buy |
8,643
+5,891
| +214% | +$200K | ﹤0.01% | 2994 |
|
|
2020
Q3 | $69K | Sell |
2,752
-328
| -11% | -$8.22K | ﹤0.01% | 3321 |
|
|
2020
Q2 | $105K | Buy |
+3,080
| New | +$105K | ﹤0.01% | 3422 |
|